Organization · Accelerator
FACIT
FACIT is an accelerator based in Toronto, Ontario, focused on the commercialization of oncology innovations. It supports the development of cancer-related technologies through investment and partnerships.
Overview
What FACIT does
What FACIT is
FACIT is an accelerator based in Toronto, Ontario, focused on the commercialization of oncology innovations. It supports the development of cancer-related technologies through investment and partnerships.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 5, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find FACIT elsewhere
Open the official website or a supported primary organization account.
Capability profile
FACIT as a funder
Investment thesis
FACIT invests in oncology innovations, focusing on therapeutics, imaging, diagnostics, and technology platforms. It employs a venture capital approach to support technologies addressing unmet oncology needs.
Focus narrative
FACIT invests in oncology innovations, including therapeutics, imaging, diagnostics, and technology platforms. It manages a diverse portfolio of Ontario oncology assets that span all stages of commercialization, from proof-of-concept to clinical development. The organization employs a venture capital approach to identify and support technologies with high potential to address unmet oncology needs. FACIT's funding initiatives include the Prospects Fund, which supports early-stage proof-of-concept studies, and the Compass Rose Fund, which aids in the early-stage development of cancer research innovations.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 35
Portfolio context
FACIT's portfolio includes over 35 companies advancing oncology therapeutics, medical technologies, diagnostics, and informatics/AI. Notable investments include: - OICR (breast cancer risk - Ontario Health Study): Focuses on diagnostics related to breast cancer risk. - Robarts Research Institute (3D ABUS device): Develops a novel wearable 3D automated breast ultrasound device. - PrecisionXRT: Specializes in stereotactic radiotherapy and radiosurgery. - Yellowbird Diagnostics Inc: Innovates a PET imaging tracer for enhanced cancer detection. - NodeAI Diagnostics: Utilizes AI to improve lung cancer biopsy precision. - Virano Therapeutics: Develops enhanced gene therapies for various cancers.
Capability profile
FACIT as a program host
Program thesis
FACIT's mission is to attract investment in oncology research and development while supporting the commercialization of innovative cancer technologies.
Focus narrative
FACIT invests in a range of oncology innovations, including therapeutics, imaging, diagnostics, and technology platforms. The organization manages a diverse portfolio of Ontario oncology assets, supporting projects from proof-of-concept to clinical development. Its funding initiatives include the Prospects Fund for early-stage studies and the Compass Rose Fund for early-stage development of cancer research innovations.
Value and support
Founders participating in FACIT's accelerator program gain access to funding, mentorship, and resources to advance their oncology innovations. The program supports the commercialization process, helping startups navigate the complexities of bringing cancer-related technologies to market.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- CanadaNorth America
Alumni and track record
Alumni context
FACIT's portfolio includes over 35 companies, such as OICR, which focuses on breast cancer diagnostics, and Robarts Research Institute, known for its 3D automated breast ultrasound device. Other notable alumni include PrecisionXRT, Yellowbird Diagnostics, NodeAI Diagnostics, and Virano Therapeutics, each contributing innovative solutions in oncology.
Common questions
What to know about FACIT
Upseed classifies FACIT under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.